We generated MRL/lpr mice deficient in the Activation Induced Deaminase (AID). Because AID is required for immunoglobulin hypermutation and class switch recombination, these mice lack hypermutated IgG antibodies. Unlike
Introduction
MRL-Fas lpr/lpr (MRL/lpr) mice develop a systemic autoimmune syndrome that shares many characteristics of human Systemic Lupus Erythematosus (SLE) [1] [2] . Like the human disease, the MRL/lpr syndrome is characterized by polygenic inheritance, the presence of circulating autoantibodies, particularly to nuclear components, and lupus nephritis development through glomerular disease, mononuclear cell infiltration, and immune complex deposition [1] [2] .
MRL/lpr mice also develop splenomegaly and lymphadenopathy, with mononuclear cell infiltration in lungs, liver, and other tissues [3] [4] . Unlike human SLE with low monozygotic twin concordance [5] , all MRL/lpr mice eventually develop the syndrome [2] . Multiple loci contribute to autoimmunity in MRL/lpr mice, suggesting the involvement of various systems. Implicated are defects in B and T cell tolerance, complement activation, cytokine regulation, endothelial cell function, and apoptotic clearance [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] .
There is compelling evidence for a role of B cells in the MRL/lpr syndrome, particularly affecting glomerulonephritis. B cell-deficient-MRL/lpr mice failed to develop glomerulonephritis [22] [23] [24] . Also important is a diverse lymphocyte repertoire, since MRL/lpr mice lacking terminal deoxynucleotidyl transferase, an enzyme that adds nucleotides to the V(D)J segments during recombination, have decreased glomerular disease [25] [26] [27] [28] [29] . However, how B cells contribute to lupus nephritis might be more complicated than previously appreciated. In addition to secreting autoantibodies, B cells might contribute to lupus nephritis as antigen-presenting cells to autoreactive T cells, and in promoting an inflammatory environment [23, [30] [31] . MRL/lpr mice lacking secreted antibodies but with B cells bearing IgM receptors, still develop a milder form of kidney disease and experience higher mortality rates than mice completely lacking B cells [32] . A hallmark feature of MRL/lpr mice lacking B cells, is a dramatic increase in the proportion of naïve CD4 + T cells with a concomitant decrease in memory or activated T cells that was reconstituted to levels similar to conventional MRL/lpr mice in mice with B cells but without secreted antibodies [32] . These results suggest an additional, autoantibody-independent B cell role in the development of lupus nephritis in MRL/lpr mice, likely through the activation of autoreactive T cells.
An aspect of B cell biology that impacts autoimmunity is the memory B cell response. B cells jointly-activated by antigen and CD4 + T cells, seed germinal centers (GC) 3 in secondary lymphoid tissues wherein their affinity to foreign antigen is enhanced by immunoglobulin (Ig) somatic hypermutation (SHM) and cellular selection [33] [34] [35] [36] [37] [38] . Isotype-class switch recombination (CSR) also occurs in the GC environment, although not Interestingly, a majority of autoantibodies in patients with SLE and in MRL/lpr mice are hypermutated and isotype-switched [39] [40] [41] [42] [43] [44] [45] [46] . In MRL/lpr mice, antibodies with mutations in the heavy chain Ig V correlate with anti-doublestranded DNA (dsDNA) specificity, particularly those introducing arginines into the CDRs [46, 47] . One could envision that since SHM is random in relation to affinity, occasionally new mutations increase affinity to selfantigens, or catastrophically, that self-antigen drives the affinity maturation reaction. Evidence of the latter scenario is found in diseases such as rheumatoid arthritis, myasthenia gravis, and Sjogren's syndrome with ectopic GC formation resulting in high affinity autoantibodies against local selfantigens [48] [49] [50] . The recent discovery of AID, a molecule critical to SHM and CSR [51] , can now provide a direct approach at examining the contribution of mutated, class-switched antibodies to the MRL/lpr mice syndrome. Since AID is required for SHM and CSR [51] [52] [53] [54] [55] , AID-deficiency blocks formation of high affinity, isotype-switched antibodies in activated B cells, without impacting B or T cell development [51] . Herein, we generated MRL/lpr mice lacking AID and examined the impact of the lack of observed was graded as follows: 1= minimal, 2= mild, 3= moderate, and 4= marked. Additional sections of kidney were stained with Period Acid Schiff stain. Glomerular change severity was graded based upon an increase in the size of affected glomeruli due to increased cellularity and mesangial matrix.
The severity of mononuclear cell infiltrate was graded based upon the total amount of infiltrate present.
The number of cells in each of 20 glomeruli per mouse was scored for the kidneys of each mouse. C57BL/6 and BALB/c mice of similar age were used as controls; the amount of mesangial matrix present in the glomeruli of controls, (approximately 10% of glomerulus), was considered the amount normally present. Lungs, lymph nodes, spleen, liver and bone marrow from each animal were examined for mononuclear cell infiltration.
Electron microscopy
Kidneys from 16-18 week-old mice collected in 3% paraformaldehyde were embedded in Spurr's resin. Approximately 80nm sections from epoxy blocks were cut, mounted on 200-mesh copper grids, stained with methanolic uranyl acetate and Reynold's lead citrate, and examined on a Zeiss 900 transmission electron microscope. A total of 40 photomicrographs from 2 representative mice from each genotype were evaluated.
Detection of urine protein level
Urine protein levels, collected monthly by expressing urine from the urethra directly, were tested with Multistix ® 10 SG (Bayer, IN) and scored as: 0, negative; 1, trace; 2 (30 mg/dl); 3 (100mg/dl); 4 (300mg/dl); 5 (2000mg/dL or more).
Blood urea nitrogen and creatinine levels in the serum
Blood urea nitrogen (BUN) and creatinine were determined by urease with the glutamate dehydrogenase (GLDH) reaction and alkaline picrate (Jaffe 
Flow cytometry
The following conjugated antibodies were used (BD PharMingen, California), following manufacturer's instructions (1 ug/million cells): rat anti-mouse CD19 PE-Cy7, rat IgG2a, κ isotype control PE-Cy7, rat anti-mouse CD45R/B220-APC-Cy7, APC-Cy7-conjugated rat IgG2a, κ isotype control, FITC-conjugated rat anti-mouse CD21/CD35 monoclonal antibody, FITCconjugated rat IgG2b, κ isotype control, biotin-conjugated rat anti-mouse CD23 (FcγRII) monoclonal antibody, biotin-conjugated IgG2a, κ isotype control, streptavidin-APC conjugate, rat anti-mouse CD4 PE, rat IgG2a, κ isotype control R-PE, rat anti-mouse CD8 APC, rat IgG2a, κ isotype control APC, anti-mouse CD44 PE-Cy5, rat IgG2b, κ isotype control PE-Cy5, antimouse CD62L FITC, rat IgG2a, κ isotype control FITC, anti-mouse CD40 R-PE, rat IgG2a, κ isotype control R-PE, anti-mouse I-A k biotin, streptavidin-APC conjugate, mouse IgG2b, κ isotype control biotin, anti-mouse CD3 PECy5, and rat IgG2b, κ isotype control PE-Cy5. 
Statistical analysis
Pairwise associations between the outcomes (lymphoid hyperplasia, glomerulo-nephritis, mononuclear cell infiltrate) were examined with the Kruskal-Wallis analysis of variance (K-W ANOVA) and Spearman's correlation coefficient. When significant differences were detected, MannWhitney tests were used to compare them to the mild severity group. To assess which combination of measures best predicted outcome severity, stepwise linear regression analysis was used.
K-W ANOVA was used to test for differences among genotypes, followed by Mann-Whitney tests to identify the differing pair of genotypes. For urine data, paired measurements on days 12-14 and days 17-19 were compared using the Wilcoxon signed-ranks test.
Differences were considered statistically significant at the 0.05 level using the Bonferroni correction for multiple testing where appropriate.
Results
To examine the role of high affinity isotype-switched antibodies in the lupuslike syndrome of MRL/lpr mice, we backcrossed AID−/− mice to MRL/lpr mice and generated 5 th (F5) and 6 th (F6) backcrossed MRL/lpr mice that were wild-type, heterozygous, or deficient in AID. In analyses where both F5 and F6 mice were examined (kidney weights, urine protein, lymphocyte populations, and anti-dsDNA IgG and IgM), the trends were nearly identical between them.
Within each genotype, lesion severity was not significantly associated with antibody levels. However, among all genotypes combined, the following trends were consistently detected for glomerulonephritis scores: with increasing glomerulonephritis severity, anti-dsDNA IgG, urine protein, and mononuclear cell infiltrates increased. Among genotype comparisons, highly significant differences were detected for most measures and are discussed below. Glomerulonephritis scores were similar between males and females (K-W ANOVA, p > 0.15) but females tended to have more severe mononuclear cell nfiltrate scores (K-W ANOVA, p = 0.007). Gender differences in mononuclear cell infiltrates cannot account for the differences among genotypes since similar gender ratios were used, and when analyzed separately for gender, the differences between the various MRL/lpr littermates remained intact.
AID deficiency in the MRL/lpr background alleviated glomerulonephritis and mononuclear cell infiltration in the kidneys
Pathological manifestations in other tissues were similar among all MRL/lpr mice and different from normal mice n the liver, a small degree of mononuclear cell infiltrates was observed in some mice of the MRL/lpr background regardless of AID status. Also, nearly all MRL/lpr mice had lymphoid hyperplasia in the spleen, and myeloid hyperplasia of the bone marrow, although the latter was reduced with AID deficiency. There was lymphoid hyperplasia in the lung that was characterized primarily by an increase in the number of lymphocytes normally present around vessels and airways and it generally affected primarily one or two lung obes rather than diffusely affecting all lobes. However, there was no difference in lung hyperplasia in AID-deficient MRL/lpr mice when compared to AID-wild type or heterozygous siblings. Also, no significant difference was detected among all MRL/lpr mice in spleen or lymph node weights (data not shown).
mproved survival with AID deficiency in MRL/lpr mice
To examine the impact of AID deficiency on lifespan, a group of F5 mice were allowed to live until multiple signs of impending death were evident as determined by at least two veterinarians (i.e. decreased activity, lowered body temperature, respiratory distress, weigh loss, etc). After 50 weeks, over 75% of the AID-wild type MRL/lpr mice; 65% of AID-heterozygous MRL/lpr mice, and 75% of the non-backcrossed MRL/lpr controls had perished while only 22% of the AID-deficient MRL/lpr had died, indicating a dramatic increase in ifespan with AID deficiency in MRL/lpr mice ( Figure 4 ; Wilcoxon test; p < 0.0001). to an antibody-independent role by B cells [32] . F5 and F6 AID-deficient MRL/lpr mice consistently displayed a slight increase in the splenic naïve CD4 + T cell population that was significant in the F6 mice but this increase was We also looked at levels of anti-dsDNA IgM. Strikingly, AID-deficient MRL/lpr mice displayed a 5-fold increase in the levels of IgM autoantibodies ( Figure   5c , K-W ANOVA, p = 0.0001). To address if this is strictly due to the AID defect, we examined anti-dsDNA IgM levels in AID-deficient C57BL/6 mice.
There was a modest increase in the levels of anti-dsDNA IgM (less than 2-fold) in the AID deficient mice compared to C57BL/6 mice (Figure 5d ) but that was 60-fold lower than in AID-deficient MRL/lpr mice, suggesting that it is the combination of AID deficiency in the MRL/lpr background contributing to exaggerated anti-dsDNA IgM levels.
To confirm serum autoantibody results, ANA tests using HEp-2 cells were done. Sera from AID wild-type MRL/lpr mice showed bright staining for IgG in the nucleus of cells, while sera from AID deficient MRL/lpr mice were negative ( Figure 6 ). Confirming high levels of autoreactive IgM antibodies, the ANA IgM stain was bright for serum from all AID −/− MRL/lpr mice, displaying two distinct patterns: strictly nuclear, and nuclear with punctate cytoplamic. There was weak IgM staining for AID wild-type MRL/lpr mice in most samples, with a few showing moderate staining (shown in Figure 6 ). If IgG vs IgM antibodies was the entire story, one would expect that the mortality rates of AID-deficient MRL/lpr mice would be similar to MRL/lpr mice with B cells but lacking secreted antibodies (mIgM) [32] . However, the mortality rates of AID-deficient MRL/lpr mice were much lower than previously reported mortality rates for mIgM mice and similar to MRL/lpr completely lacking B cells (J H D), even though mortality for AID wild-type MRL/lpr, and non-backcrossed MRL/lpr mice in this and the previous study were nearly identical (Table 1) . This led us to speculate that the lack of high affinity autoreactive B cells (and not just their antibodies) in AID-deficient MRL/lpr mice might also contribute to reduced disease and mortality in these mice. Shlomchik and colleagues [23, 32] , demonstrated that an indication of a direct role of B cells in the lupus syndrome of MRL/lpr mice is the activation of splenic CD4 + T cells. For example, MRL/lpr mice lacking B cells displayed a near 10-fold increase in the proportion of naïve T cells with a concomitant decrease in memory T cells, which was restored in the non-secreting mice [32] . There was only a modest increase (2-fold) in the proportion of naïve T cells in AID-deficient MRL/lpr mice, and no consistent pattern emerged suggesting a decrease in the proportion of activated or memory T cells. Also, although B cells from the AID-deficient MRL/lpr mice cannot hypermutate, these mice have a full naïve B cell repertoire, while the mIgM mice have a limited repertoire. These results suggest, at best, a modest contribution by B cells to the difference in mortality between AID-deficient and wild-type MRL/lpr littermates. Instead, since non-hypermutated germline-encoded natural IgM has been implicated in apoptotic-cell clearance at injury sites, minimizing inflammation [71] [72] [73] [74] , it may be that AID-deficient MRL/lpr mice have high levels of natural IgM antibodies, and these antibodies play a protective role as suggested by some studies using monoclonal autoreactive IgM antibodies [69] . Indeed, the dramatic reduction in lymphocyte infiltration in the kidneys of AID-deficient MRL/lpr mice is consistent with decreased inflammation. Interestingly, Nemazee and colleagues recently reported that lpr mice lacking secreted IgM but with high levels of secreted IgG and other isotypes (μMT/lpr mice), the converse situation than for AID-deficient MRL/lpr mice, experienced accelerated autoimmunity and autoantibody production compared to lpr mice, possibly suggesting a protective role for IgM [75] . Ongoing studies examining the effects of passive transfer of autoreactive polyclonal and monoclonal IgM antibodies from AID-deficient MRL/lpr mice into AID wild-type MRL/lpr mice and autoreactive IgG into AIDdeficient MRL/lpr mice, will enable us to directly examine these hypotheses and perhaps help delineate the characteristics of protective and/or
Discussion

